2014 Career & Salary Survey
Although job-cut announcements have become a part of daily life in the industry, average salaries have risen to an all-time high. Not only that, job satisfaction is up in pharma. However, this doesn't seem to prevent more people than ever looking to move, finds James Chase
Salaries are down,the industry gender gap persists and people have their eyes peeled for better gigs. But job satisfaction remains positive and, compared with other businesses, the pay isn't half-bad. James Chase attempts to make sense of the seeming contradictions
The 26th MM&M Career & Salary Survey reports that average salaries are slightly outpacing inflation. To get the whole story, download a copy of the full report.
Despite the job cuts that have darkened the pharma job market, top talent will always be in demand—and most respondents to MM&M's 25th Career & Salary Survey seem fairly content. James Chase reports
Following last year's unprecedented decreases, average salaries have bounced back to 2008 levels. Is the storm finally passing? James Chase reports on the key findings of the Career & Salary Survey 2010
Featuring hundreds of additional insights on salaries, benefits, motivations, job satisfaction, attitudes, and employment trends in the healthcare marketing sector.
The brutal economic landscape is taking its toll on industry paychecks--for the first time in years, MM&M's exclusive research shows a decrease in average salary. Ben Comer looks at the data on pay, job satisfaction and migration
Pharma companies and agencies are answering the call for bigger paychecks and better working environments as the battle for top talent heats up.
Just landed a new job? You've got 100 days to make an impression. Here are some suggestions.
Shane Mayer, VP, client services at InTouch Solutions
Cindy Whitehead, CEO, Sprout Pharmaceuticals
MAHF 2015 Heritage Ad Awards will be given to campaigns for Bentyl, Hytrin and Navane
President, Advertising, inVentiv Health
Ruby Gadelrab. VP, commercial marketing, 23andMe
Sanofi vets Takeda, devicemaker CEO candidates; Shaq returns for IcyHot; Royalty Pharma buys royalties on Vertex's Kalydeco.
Jose Rivera. EVP, account director, Concentric
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.